Yoshiji Miwa
- Urology top 1%
- Urinary Bladder and Prostate Research 15
- Rheumatology top 5%
- Pelvic floor disorders treatments 7
-
- Prostate Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 4
-
- Bladder and Urothelial Cancer Treatments 5
-
- Urinary Tract Infections Management 5
-
- Renal and related cancers 4
Yoshiji Miwa
34 papers receiving 524 citations
Peers
Comparison fields: 5 of 70
- Urology 323
- Rheumatology 177
- Endocrinology, Diabetes and Metabolism 110
- Sensory Systems 24
- Pulmonary and Respiratory Medicine 155
Countries citing papers authored by Yoshiji Miwa
This map shows the geographic impact of Yoshiji Miwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiji Miwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiji Miwa more than expected).
Fields of papers citing papers by Yoshiji Miwa
This network shows the impact of papers produced by Yoshiji Miwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiji Miwa. The network helps show where Yoshiji Miwa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshiji Miwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 17 | |
| 2 | 2011 | 6 | |
| 3 | 2011 | 7 | |
| 4 | Relationship between nocturia and metabolic syndrome | 2009 | 2 |
| 5 | 2009 | 40 | |
| 6 | 2008 | 20 | |
| 7 | 2008 | 15 | |
| 8 | 2008 | 38 | |
| 9 | 2008 | 28 | |
| 10 | 2007 | 4 | |
| 11 | 2006 | 37 | |
| 12 | 2006 | 20 | |
| 13 | 2006 | 37 | |
| 14 | 2001 | 14 | |
| 15 | 2000 | 16 | |
| 16 | 1999 | 10 | |
| 17 | 1999 | 12 | |
| 18 | 1997 | 8 | |
| 19 | 1996 | 2 | |
| 20 | [Cavernous angioma in the cerebellopontine angle: a case report]. | 1993 | 5 |
About Yoshiji Miwa
Yoshiji Miwa is a scholar working on Urology, Rheumatology, Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Psychiatry and Mental health, having authored 36 papers that have together received 531 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (15 papers), Pelvic floor disorders treatments (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Urinary Tract Infections Management (5 papers), Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Urology (323 citations), Rheumatology (177 citations), Endocrinology, Diabetes and Metabolism (110 citations), Sensory Systems (24 citations) and Pulmonary and Respiratory Medicine (155 citations). Yoshiji Miwa has collaborated with scholars based in Japan and United States. Frequent co-authors include Osamu Yokoyama, Hironobu Akino, Nobuyuki Oyama, Yoshitaka Aoki, Hideaki Ito, Yosuke Matsuta, Kenichiro Okada, Kazuya Tanase, Hiroshi Kanamaru and Hidehiko Okazawa. Their work appears in journals such as The Journal of Urology, Urology, International Journal of Urology, Neurourology and Urodynamics and The Journal of Sexual Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.